Literature DB >> 24716687

Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.

Rachelle S Doody, Martin Farlow, Paul S Aisen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24716687     DOI: 10.1056/NEJMc1402193

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  29 in total

Review 1.  The Proteasome and Oxidative Stress in Alzheimer's Disease.

Authors:  Vicent Bonet-Costa; Laura Corrales-Diaz Pomatto; Kelvin J A Davies
Journal:  Antioxid Redox Signal       Date:  2016-08-25       Impact factor: 8.401

2.  Aβ vaccination in combination with behavioral enrichment in aged beagles: effects on cognition, Aβ, and microhemorrhages.

Authors:  Paulina R Davis; Ginevra Giannini; Karin Rudolph; Nathaniel Calloway; Christopher M Royer; Tina L Beckett; M Paul Murphy; Frederick Bresch; Dieter Pagani; Thomas Platt; Xiaohong Wang; Amy Skinner Donovan; Tiffany L Sudduth; Wenjie Lou; Erin Abner; Richard Kryscio; Donna M Wilcock; Edward G Barrett; Elizabeth Head
Journal:  Neurobiol Aging       Date:  2016-09-26       Impact factor: 4.673

Review 3.  A short perspective on the long road to effective treatments for Alzheimer's disease.

Authors:  David S Reynolds
Journal:  Br J Pharmacol       Date:  2019-03-01       Impact factor: 8.739

Review 4.  Efficacy of curcumin for age-associated cognitive decline: a narrative review of preclinical and clinical studies.

Authors:  Marjana Rahman Sarker; Susan F Franks
Journal:  Geroscience       Date:  2018-04-21       Impact factor: 7.713

5.  Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs.

Authors:  Holly Posner; Rosie Curiel; Chris Edgar; Suzanne Hendrix; Enchi Liu; David A Loewenstein; Glenn Morrison; Leslie Shinobu; Keith Wesnes; Philip D Harvey
Journal:  Innov Clin Neurosci       Date:  2017-02-01

Review 6.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

7.  Delayed clearance of cerebrospinal fluid tracer from entorhinal cortex in idiopathic normal pressure hydrocephalus: A glymphatic magnetic resonance imaging study.

Authors:  Per K Eide; Geir Ringstad
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-27       Impact factor: 6.200

Review 8.  The multiplex model of the genetics of Alzheimer's disease.

Authors:  Rebecca Sims; Matthew Hill; Julie Williams
Journal:  Nat Neurosci       Date:  2020-02-28       Impact factor: 24.884

9.  West Nile Virus-Induced Neurologic Sequelae-Relationship to Neurodegenerative Cascades and Dementias.

Authors:  Amy Y Vittor; Maureen Long; Paramita Chakrabarty; Lauren Aycock; Vidya Kollu; Steven T DeKosky
Journal:  Curr Trop Med Rep       Date:  2020-02-18

Review 10.  Searching the Dark Genome for Alzheimer's Disease Risk Variants.

Authors:  Rachel Raybould; Rebecca Sims
Journal:  Brain Sci       Date:  2021-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.